NRAS and neoplasm: Therefore, the observed associations between the expressions of the SEMA7A, SEMA4D, ADAM8, and ADAMTS10 in tumor groups with KRAS, NRAS, BRAF, PIK3CA, and AKT mutations require validation in larger study cohorts.